Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 3466 AL 3480

Validity of the Functional Gait Assessment in patients with Parkinson disease: construct, concurrent, and predictive validity

Yang Y, Wang Y, Zhou Y, Chen C, Xing D, Wang C.

Phys Ther. 2014 Mar;94(3):392-400. doi: 10.2522/ptj.20130019. Epub 2013 Oct 24.

The impact of non-motor symptoms on the Health-Related Quality of Life of Parkinson's disease patients from Southwest China

Song W, Guo X, Chen K, Chen X, Cao B, Wei Q, Huang R, Zhao B, Wu Y, Shang HF.

Parkinsonism Relat Disord. 2014 Feb;20(2):149-52. doi: 10.1016/j.parkreldis.2013.10.005. Epub 2013 Oct 15.

The innate and adaptive immunological aspects in neurodegenerative diseases

Rodrigues MC, Sanberg PR, Cruz LE, Garbuzova-Davis S.

J Neuroimmunol. 2014 Apr 15;269(1-2):1-8. doi: 10.1016/j.jneuroim.2013.09.020. Epub 2013 Oct 5.

60-Hz frequency effect on gait in Parkinson's disease with subthalamic nucleus deep brain stimulation

Phibbs FT, Arbogast PG, Davis TL.

Neuromodulation. 2014 Dec;17(8):717-20; discussion 720. doi: 10.1111/ner.12131. Epub 2013 Oct 24.

Parkinson's disease and occupation: differences in associations by case identification method suggest referral bias

Teschke K, Marion SA, Tsui JK, Shen H, Rugbjerg K, Harris MA.

Am J Ind Med. 2014 Feb;57(2):163-71. doi: 10.1002/ajim.22272. Epub 2013 Oct 25.

An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease

Hatano T, Hattori N, Kawanabe T, Terayama Y, Suzuki N, Iwasaki Y, Fujioka T; Yokukansan Parkinson’s Disease Study Group.

J Neural Transm (Vienna). 2014;121(3):275-81. doi: 10.1007/s00702-013-1105-y. Epub 2013 Oct 30.

Escitalopram-induced Parkinsonism

Ak S, Anıl Yağcıoğlu AE.

Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):126.e1-2. doi: 10.1016/j.genhosppsych.2013.09.010. Epub 2013 Oct 5.

Two cases of pregnancy in Parkinson's disease

Lamichhane D, Narayanan NS, Gonzalez-Alegre P.

Parkinsonism Relat Disord. 2014 Feb;20(2):239-40. doi: 10.1016/j.parkreldis.2013.10.013. Epub 2013 Oct 20.

STN-DBS does not change emotion recognition in advanced Parkinson's disease

Albuquerque L, Coelho M, Martins M, Guedes LC, Rosa MM, Ferreira JJ, Cattoni MB, Carvalho H, Ferreira AG, Martins IP.

Parkinsonism Relat Disord. 2014 Feb;20(2):166-9. doi: 10.1016/j.parkreldis.2013.10.010. Epub 2013 Oct 18.

Mobility, mood and site of care impact health related quality of life in Parkinson's disease

Nutt JG, Siderowf AD, Guttman M, Schmidt PN, Zamudio JI, Wu SS, Okun MS, Simuni T, Parashos SA, Dahodwala NA, Davis TL, Giladi N, Gurevich T, Hauser RA, Jankovic J, Lyons KE, Marsh L, Miyasaki JM, Morgan JC, Santiago AJ, Tarsy D, Mari Z, Malaty IA, Nelson EC; National Parkinson Foundation Quality Improvement Initiative Investigators.

Parkinsonism Relat Disord. 2014 Mar;20(3):274-9. doi: 10.1016/j.parkreldis.2013.10.004. Epub 2013 Oct 16.

Triad-conditioning transcranial magnetic stimulation in Parkinson's disease

Hanajima R, Terao Y, Shirota Y, Ohminami S, Tsutsumi R, Shimizu T, Tanaka N, Okabe S, Tsuji S, Ugawa Y.

Brain Stimul. 2014 Jan-Feb;7(1):74-9. doi: 10.1016/j.brs.2013.09.013. Epub 2013 Oct 2.

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial

Cummings J, Isaacson S, Mills R, Williams H, Chi-Burris K, Corbett A, Dhall R, Ballard C.

Lancet. 2014 Feb 8;383(9916):533-40. doi: 10.1016/S0140-6736(13)62106-6. Epub 2013 Nov 1.

Parkinson's disease patients first treated at age 75 years or older: a comparative study

Peretz C, Chillag-Talmor O, Linn S, Gurevich T, El-Ad B, Silverman B, Friedman N, Giladi N.

Parkinsonism Relat Disord. 2014 Jan;20(1):69-74. doi: 10.1016/j.parkreldis.2013.09.020. Epub 2013 Oct 18.

Comparison of the clinical profile of Parkinson's disease between Spanish and Cameroonian cohorts

Cubo E, Doumbe J, Martinez-Martin P, Rodriguez-Blazquez C, Kuate C, Mariscal N, Lopez I, Noubissi G, Mapoure YN, Jon JL, Mbahe S, Tchaleu B, Catalan MJ; ELEP Group.

J Neurol Sci. 2014 Jan 15;336(1-2):122-6. doi: 10.1016/j.jns.2013.10.021. Epub 2013 Oct 22.

Leg muscle power is enhanced by training in people with Parkinson's disease: a randomized controlled trial

Paul SS, Canning CG, Song J, Fung VS, Sherrington C.

Clin Rehabil. 2014 Mar;28(3):275-88. doi: 10.1177/0269215513507462. Epub 2013 Nov 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias